MDLZ
36
4
MOS
46
-3
RRC
58
5
EQT
54
3
ICE
59
2
EOG
58
9
FLS
78
3
NI
68
5
AA
63
7
HRB
59
-7
CTSH
65
2
SWK
62
-2
INTU
60
2
STI
17
10
MCO
77
7
ES
31
3
AVGO
42
-2
DLTR
31
-3
BEN
34
-3
AMAT
50
-3
MDLZ
36
4
MOS
46
-3
RRC
58
5
EQT
54
3
ICE
59
2
EOG
58
9
FLS
78
3
NI
68
5
AA
63
7
HRB
59
-7
CTSH
65
2
SWK
62
-2
INTU
60
2
STI
17
10
MCO
77
7
ES
31
3
AVGO
42
-2
DLTR
31
-3
BEN
34
-3
AMAT
50
-3
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
87

CORT
Corcept Therapeutics

Last Price:
59.57
Seasonality Move:
3.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Corcept Therapeutics Price Quote

$59.57
-0.03 (9.71%)
(Updated: November 9, 2024 at 5:19 AM ET)

Corcept Therapeutics Key Stats

Buy
87
Corcept Therapeutics (CORT) is a Buy
Day range:
$54.30 - $61.66
52-week range:
$20.84 - $61.66
Dividend yield:
0%
P/E ratio:
63.40
P/S ratio:
10.57
P/B ratio:
9.78%
Volume:
1.7M
Avg. volume:
1.1M
1-year change:
131.37%
Market cap:
$6.2B
Revenue:
$482.4M
EPS:
$1.26

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.46%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $144.7M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$23M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$96.1M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 25.77%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 21.04%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 25.77%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 46.43% 41.38%
Revenue: 47.69% 6.15%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 74.90
Upside from Last Price: 25.67%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    132.6M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.5M CORT shares are owned by insiders